|
|
| Model Number |
DS960HS |
| Medical Device Problem Code |
Degraded (1153)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/15/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The capa process identified complaints not being created for quality issues found during third party servicing.Based on a review of records impacted by the identified issue, it was determined that this record needed to be corrected and is now being submitted accordingly.
|
| |
|
Event or Problem Description
|
|
The manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.A bipap autosv adv device was returned to a third-party service center with no initial alleged complaint.During the evaluation of the device at the service center, the device was visually inspected, and no foam particles were noted in the airpath, yet foam degradation was noted.The devices sound abatement foam was replaced to address the issue.The device was scrapped by the service center after the evaluation was completed.
|
| |
|
Additional Manufacturer Narrative
|
|
This report is being sent to correct our previous submission.The device was returned as part of a field action for foam replacement.No malfunction or adverse event was reported from the field.No evidence of foam degradation or particulate matter was identified during evaluation.Based on the available information, this event does not meet the criteria for a reportable serious incident.
|
| |
|
Additional Manufacturer Narrative
|
|
In previously submitted report, product brand name, fda product code and common device name in box d, health impact grid and recall (z) number in box h were incorrect.In this report, product brand name, fda product code and common device name in box d, health impact grid and recall (z) number in box h has been updated/corrected.The affected products with field complaints alleging pe-pur foam degradation have undergone the establishment of complaint codes specifically identifying foam degradation, for dreamstation asv, st/avaps.A field correction action(2021-06-a) was initiated, and medical device recall letters were issued.A field action was initiated to replace pe-pur foam in affected products; degradation was added to the respective dfmeas and the risk management file that was current at the time ¿ er 2229075 (kahootz risk management matrix) was updated to include hazards associated with foam degradation based on complaints analyzed through various health hazard evaluations (hhes).Risk tags ¿ degrad06, irrit05 reflected the safety risk assessment of design containing the affected pe-pur foam.These complaints were monitored and trended in accordance with the complaint trending procedures.If the complaints were determined to meet the criteria for escalation, they were escalated for risk assessment through the post market clinical escalation process.As of the date of submission for this report, there is no indication that complaints for the failure in question have led to unacceptable levels of severity or probabilities of harm, and therefore no further action will be pursued.
|
| |
|
Search Alerts/Recalls
|
|
|